GHS-R1a agonism
Studied at the ghrelin receptor, a distinct target from the GHRH receptor engaged by sermorelin and CJC-1295.
These are results measured on this lot. Full material specification is in Know your compound.
Growth Hormone Secretagogue
A selective pentapeptide agonist at the ghrelin (GHS-R1a) receptor.
$40.00 per vial with BOGO
Research use only — not for human or veterinary use, diagnostic or therapeutic.
Know your compound
Ipamorelin is a five-residue synthetic peptide that acts as an agonist at the growth-hormone secretagogue receptor GHS-R1a — the same receptor engaged by the endogenous hormone ghrelin. It belongs to a different pharmacological class from the GHRH analogs, despite frequently being stocked alongside them.
What makes ipamorelin notable in the published literature is selectivity. Earlier secretagogues in this class showed activity across additional endocrine axes; ipamorelin was characterised as engaging GHS-R1a with comparatively little cross-activity, which is why it became a standard reference tool for isolating this receptor in experimental work.
Supplied as a lyophilized powder for laboratory research use only, with a lot-specific Certificate of Analysis.
Read left to right from the N-terminus. Mass spectrometry checks each lot against this sequence — that result is the “Identity” line on the certificate.
What the molecule is.
How we know the material matches the label.
What arrives, and how it is kept.
What the literature examines
Summaries of what published research has investigated. Preclinical unless stated otherwise — not claims about this product.
Studied at the ghrelin receptor, a distinct target from the GHRH receptor engaged by sermorelin and CJC-1295.
Published work characterises limited cross-activity relative to earlier compounds in the secretagogue class.
At five residues it is among the shortest peptides in the catalog with a well-defined receptor target.
Certificate of Analysis
Not a brand-wide spec sheet — a lot-specific certificate from an independent laboratory, published before the lot ships and searchable by lot number forever.
Independent U.S. laboratory
Certificate of Analysis · RFX-2606-130
| Test | Specification | Result |
|---|---|---|
| Purity (HPLC) | ≥ 99.0% | 99.4% |
| Identity (LC-MS) | Conforms | Conforms |
| Appearance | White powder | Conforms |
| Net content | Label claim | Conforms |
Questions
No. Ipamorelin is not an FDA-approved drug and is not approved for human or veterinary use. It is supplied exclusively as a research material for laboratory use, and it is not intended to diagnose, treat, cure, or prevent any disease.
Yes. Every lot is assayed by an independent U.S. laboratory for purity and identity, and the certificate for the lot you receive is published in our COA library — you can read it before you order.
Purity is quantified by reverse-phase HPLC against a reference standard, and identity is confirmed by mass spectrometry. Both results appear on the lot certificate.
Lyophilized material is typically stored cold and protected from light. Handling and storage are the responsibility of the receiving laboratory; refer to the lot documentation for specifics.
Every second vial is free, sitewide and automatically. Add two vials and you pay for one; add six and you pay for three. Compounds can be mixed, there is no code, and there is no limit.
Orders are processed promptly and shipped with tracking. Free US shipping applies over $100; Priority shipping is $8.95 otherwise.
The guarantee
Have any lot independently re-tested. If the results don't match the purity printed on its published certificate, we refund the order in full — no returns, no argument.